Objective This study aimed to examine whether biomarker tests—finger-prick, skin-prick and offline fractional exhaled nitric oxide (FeNO)—are acceptable and feasible as a guide to treatment decisions, ...
The Columbia Overseas Value Fund outperformed its benchmark with an 8.70% return for the quarter ending September 30, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results